Gilead Sciences Ltd

Active status, holding company, founded 35 years ago, revenue range: 54m+, real address, 5 directors, 1 owner, located in London. Regular importer of various medicines not listed elsewhere, medicines with other antibiotics, cell therapy products, various plastic boxes and cases, data transmission devices (213.0 months imported). Regular exporter of data transmission devices, portable computers, large plastic bottles (over 2 liters), retail immunological products, cell therapy products (52.0 months exported). Operates in the wholesale, the pharma products industries.

Gilead Sciences Inc owns this company. The list of owners was changed ten years ago. It is not exhaustive, as only owners with more than twenty five percent of shares are published.

Marin-lazaro Juan Peche, Yang Comiskey Josephine, Wickersham Peter, Mckenzie Ian, Stcker Hans York-julian are the directors of this company. The list of directors was changed one year ago.

The company was incorporated thirty five years ago on September 27, 1990.

The registration address is WC1V 7EE, London, 280 High Holborn. The address is real address as one company registered at the address.

The company was previously Nexstar Pharmaceuticals Limited, Vestar Limited, Maplestore Limited.

The top import category of the regular importer company is Various medicines not listed elsewhere, Medicines with other antibiotics, Cell therapy products, Various plastic boxes and cases, Data transmission devices, imported for 213.0 months. The last import operation was made on January 01, 2026.

The top export category of the regular exporter company is Data transmission devices, Portable computers, Large plastic bottles (over 2 liters), Retail immunological products, Cell therapy products, exported for 52.0 months. The last export operation was made on January 01, 2026.

The company exports to Belgium, France, Germany, India, Ireland, Japan, Netherlands, Norway, Saudi Arabia, Slovakia, Switzerland, and United States. (non-official data, calculated by Corpsignals)

The company imports from Austria, Bangladesh, Belgium, China, China, Hong Kong Special Administrative Region, China, Macao Special Administrative Region, Denmark, France, Germany, India, Ireland, Italy, Japan, Netherlands, Poland, Romania, Spain, Switzerland, and United States. (non-official data, calculated by Corpsignals)

The company uses the following ports for trade: Belfast Port, Dover, Dover / Eurotunnel, East Midlands Airport, Eurotunnel, Felixstowe, Hull, Immingham Docks, Liverpool Docks, London Gateway Port, London Heathrow Airport, London Stansted Airport, Manchester Airport, Southampton, and Tyne. (non-official data, calculated by Corpsignals)

The company uses Air transport, Roll on Roll off (RORO), and Sea transport (not vehicle on ferry) for trade. (non-official data, calculated by Corpsignals)

The company operates in the wholesale, the pharma products industries.

It's a large company as it met two conditions of three: turnover more than £36 million, balance sheet more than £18 million, employees more than 250.

CorpSignals sources its data from UK government records including Companies House and HMRC trade data. Data is updated every 24 hours. While we ensure accuracy through automated validation, please refer to original government sources for legal or compliance purposes.